Skip to main content
S 3431 114th Congress Senate Health

Scleroderma and Fibrosis Research Enhancement Act of 2016

Introduced: September 28, 2016 Introduced by: Gillibrand, Kirsten E. Democratic · New York See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 28, 2016
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 28, 2016
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Scleroderma and Fibrosis Research Enhancement Act of 2016

This bill requires the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to establish the National Commission on Scleroderma and Fibrosis Research. (Scleroderma and fibrosis are connective tissue conditions that cause hardening or scarring of skin and organs.)

The commission must develop a long-term, comprehensive plan for scleroderma and fibrosis research. The plan must: (1) prioritize research that has cross-cutting value and requires coordination across NIH, and (2) include specific steps for implementation of the research.

The commission must establish working groups to make research recommendations for the various organs and systems impacted by fibrotic illness.

The commission must be terminated not later than two years after establishment.

The NIAMS must create the Scleroderma and Fibrosis Working Group to oversee and assist with implementation of the long-term plan.
What's happening now September 28, 2016

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • HR 3666 Related bill Scleroderma and Fibrosis Research Enhancement Act of 2015
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 1 Republican 1
R
Collins, Susan M.
Maine · Nov 15, 2016
 D
Schumer, Charles E.
New York · Sep 28, 2016
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3431: Scleroderma and Fibrosis Research Enhancement Act of 2016. 114th Congress. Open America. https://openamerica.io/bill/114-S-3431/
MLA
"S. 3431: Scleroderma and Fibrosis Research Enhancement Act of 2016." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-S-3431/.
Bluebook (legal)
S. 3431, 114th Cong. (2026), https://openamerica.io/bill/114-S-3431/.
Markdown link
[S. 3431: Scleroderma and Fibrosis Research Enhancement Act of 2016](https://openamerica.io/bill/114-S-3431/)
Report a problem